![Jack Higgins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Higgins
Technik-/Wissenschafts-/F&E-Leiter bei
IMMUNOME, INC.
Vermögen: 545 750 $ am 31.05.2026
Profil
Jack Higgins currently works at Immunome, Inc., as Chief Scientific Officer from 2023.
Dr. Higgins also formerly worked at Molecular Templates, Inc., as Chief Development Sciences Officer, Molecular Templates, Inc., as Chief Development Sciences Officer from 2019 to 2021, and MorphImmune, Inc., as Chief Scientific Officer from 2022 to 2023.
Dr. Higgins received his undergraduate degree from Texas A&M University and graduate degree and doctorate degree from The University of Arkansas.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0.02% | 02.04.2026 | 25’000 ( 0.02% ) | 545 750 $ | 31.05.2026 |
Aktive Positionen von Jack Higgins
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2023 |
Ehemalige bekannte Positionen von Jack Higgins
| Unternehmen | Position | Ende |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2023 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Geschäftsführer | 01.06.2019 |
| MOLECULAR TEMPLATES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jack Higgins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
